The goal of this proposal is we aim to develop an injectable drug delivery system for intratumoral delivery of a combination of an AXL-inhibitor and FDA-approved chemotherapy drug (e.g.Dox). AXL inhibitors in combination with chemotherapies that target the DNA of cancer cells is a promising approach for treating cancers. The device is integrable to a […]
Read More